Kim Hun, Hwang Kun, Yun Seon Mi, Kim Dae Joong
Department of Plastic Surgery.
Department of Anatomy, Inha University School of Medicine, Incheon, Korea.
J Craniofac Surg. 2020 May/Jun;31(3):791-793. doi: 10.1097/SCS.0000000000006156.
Plastic surgeons commonly administer subcutaneous epinephrine to reduce intraoperative blood loss. The authors hypothesized that there are safe and effective concentration of epinephrine for vasoconstriction and their durations. The aim of this study is to summarize the existing literatures for the usage of epinephrine mixed with lidocaine in plastic surgical field.In 1903, Braun reported that adrenaline prolonged the local anesthetic effects of cocaine. The Parke-Davis Company began selling cocaine with adrenaline, as well as combining adrenaline with new synthetic local anesthetics.Based on a review of the literature, concentrations between 1:50,000 and 1:400,000 are equally effective and provide superior vasoconstriction compared with more dilute solutions. If epinephrine is further diluted, its onset and time to peak serum concentration are delayed, and its duration of action is shortened. When lidocaine is used without epinephrine, duration of anesthesia is shortened reverse proportionally to the lidocaine concentration. When lidocaine is used with epinephrine, duration of anesthesia is prolonged proportionally to the lidocaine concentration. With slow injection rate in the soft tissue, the maximum safe dose of lidocaine is approximately 3 mg/kg plain and 7 mg/kg when mixed with epinephrine. Lidocaine may protect the myocardium because of its antiarrhythmic activity, which is the rationale for infiltrating lidocaine mixed with epinephrine in general anesthesia.In plastic surgery, subcutaneous infiltration of epinephrine-lidocaine solution is performed to reduce intraoperative blood loss. Even in general anesthesia, infiltrating lidocaine mixed with epinephrine may protect the myocardium because of its antiarrhythmic activity.
整形外科医生通常会注射皮下肾上腺素以减少术中失血。作者推测,存在安全有效的肾上腺素浓度用于血管收缩及其持续时间。本研究的目的是总结整形外科领域中肾上腺素与利多卡因混合使用的现有文献。1903年,布劳恩报告称肾上腺素可延长可卡因的局部麻醉效果。帕克-戴维斯公司开始销售含肾上腺素的可卡因,以及将肾上腺素与新的合成局部麻醉剂混合。基于文献综述,1:50,000至1:400,000之间的浓度同样有效,并且与更稀释的溶液相比,能提供更好的血管收缩效果。如果肾上腺素进一步稀释,其起效时间和血清浓度达到峰值的时间会延迟,作用持续时间会缩短。当不使用肾上腺素使用利多卡因时,麻醉持续时间与利多卡因浓度成反比缩短。当利多卡因与肾上腺素一起使用时,麻醉持续时间与利多卡因浓度成正比延长。在软组织中缓慢注射时,利多卡因的最大安全剂量纯品约为3mg/kg,与肾上腺素混合时为7mg/kg。利多卡因因其抗心律失常活性可能对心肌有保护作用,这就是在全身麻醉中浸润注射利多卡因与肾上腺素混合物的理论依据。在整形外科中,进行肾上腺素-利多卡因溶液的皮下浸润以减少术中失血。即使在全身麻醉中,浸润注射利多卡因与肾上腺素的混合物也可能因其抗心律失常活性而对心肌有保护作用。